
Kaneka Corporation
4118.TJPXBasic MaterialsChemicals - Specialty
Latest quote
¥6,183
−¥2.00 · -0.03%
4118.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteKaneka Corporation, established in Tokyo, Japan, in 1949, operates internationally as a diversified manufacturer providing a wide array of advanced materials and specialized products. Its core chemical business includes the production and global distribution of various polyvinyl chloride (PVC) formulations, such as crosslinked, paste, and chlorinated PVC, alongside acryl grafted-vinyl chloride copolymers. The company also supplies critical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Furthermore, their portfolio features advanced polymers including silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, and engineering resins designed for injection molding, in addition to zero birefringence materials, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond chemicals, Kaneka manufactures specialized foams and films, encompassing polypropylene and Kanelite foams, extruded polystyrene insulation, polyimide films, and transparent films for optical applications. Their material science expertise extends to high thermal conductive graphite sheets, multi-layer insulation, transparent conductive films, and transparent resins engineered for exceptional heat and light resistance. In the energy and innovative products sector, Kaneka offers photovoltaic power generation systems suitable for residential, public, and industrial installations. Other cutting-edge developments include eco-friendly fur, flame-retardant materials, hair accessories, novel materials, organic EL lighting panels, and biosurfactants. Their life sciences division delivers a comprehensive range of medical and pharmaceutical offerings, which include intervention and blood purification systems, gastroenterology intervention tools, diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostics. Additionally, they provide low molecular pharmaceutical raw materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and innovative shock-absorbing innerwear. Lastly, Kaneka is a significant player in the food and nutrition industry. Their extensive product line features dairy products, margarines, fats and oils, whipping creams, fillings, baking essentials (baker's yeast, dough improvers), processed fruits, butter, shortening, cacao butter alternatives, various creams, frozen dough, spices, and antifreeze materials. They also supply pharmaceutical and supplemental nutrition solutions, such as coenzyme Q10, lactic-acid bacteria, and functional foodstuffs, alongside agricultural fertilizers.
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- Headquarters
- JP
- CEO
- Kazuhiko Fujii
- Listed since
- Jan 1, 2001
- Employees
- 11,762
Market position
- Volume
- 207.1K
- 0.84× average
- Average volume
- 246.51K
- Average daily volume
- Market cap
- 372.37B JPY
- Beta
- 0.32
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 476.67B JPY
- P/E (TTM)
- 10.6×
- P/B (TTM)
- 0.74×
- P/S (TTM)
- 0.45×
- EV / EBITDA
- 4.95×
- Earnings yield
- 10.45%
- Free cash flow yield
- 0.46%
- Dividend yield
- 2.59%
Profitability & efficiency
- Gross margin
- 28.19%
- Operating margin
- 4.60%
- Net margin
- 4.27%
- Return on equity
- 6.20%
- Return on assets
- 3.23%
- Return on invested capital
- 2.89%
Financial health
- Debt / equity
- 0.45×
- Current ratio
- 1.53×
- Altman Z-score
- 2.24
- Piotroski F-score
- 5 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 811.64B JPY | 807.2B JPY | 762.3B JPY | 755.82B JPY | 691.53B JPY |
| Cost of goods sold | 587.35B JPY | 590.98B JPY | 567.1B JPY | 565.35B JPY | 501.1B JPY |
| Gross profit | 224.29B JPY | 216.23B JPY | 195.2B JPY | 190.47B JPY | 190.43B JPY |
| Research and development | — | 39.34B JPY | 35.4B JPY | 32.67B JPY | 30.89B JPY |
| Selling, general, and administrative | 192.66B JPY | 137.85B JPY | 128.4B JPY | 123.86B JPY | 115.97B JPY |
| Operating expenses | 192.66B JPY | 177.19B JPY | 163.8B JPY | 156.53B JPY | 146.87B JPY |
| Interest income | 275M JPY | 295M JPY | 224M JPY | 222M JPY | 178M JPY |
| Interest expense | 4.09B JPY | 4.03B JPY | 3.36B JPY | 1.97B JPY | 1.06B JPY |
| Depreciation and amortization | 47.43B JPY | 44.66B JPY | 41.45B JPY | 40.11B JPY | 38.51B JPY |
| Operating income | 31.64B JPY | 39.04B JPY | 31.41B JPY | 33.94B JPY | 43.56B JPY |
| Net income | 30.98B JPY | 25.31B JPY | 23.22B JPY | 23.01B JPY | 26.49B JPY |
Company facts updated Aug 24, 2026.
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥150
2025 complete year+50.0% since 2021
2026 partial: ¥80.00
¥100
2,021
¥115
2,022
¥110
2,023
¥115
2,024
¥150
2,025
¥80.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥105Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥105Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥80.00Semi-Annual | Mar 31, 2026 | Jun 5, 2026 |
Dividend | Sep 29, 2025 | ¥80.00Semi-Annual | Sep 30, 2025 | Dec 5, 2025 |
Dividend | Mar 28, 2025 | ¥70.00Semi-Annual | Mar 31, 2025 | Jun 6, 2025 |
Dividend | Sep 27, 2024 | ¥60.00Semi-Annual | Sep 30, 2024 | Dec 5, 2024 |
Ex-dividend Sep 29, 2026
¥105
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥105
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥80.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 5, 2026
Ex-dividend Sep 29, 2025
¥80.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 5, 2025
Ex-dividend Mar 28, 2025
¥70.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 6, 2025
Ex-dividend Sep 27, 2024
¥60.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 5, 2024
4118.T peers
Continue in GoAI
Research 4118.Tresearch.disclaimer





